PFIZER | November 09, 2020 | Read the originally published press release here Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis … Continued
The post PFIZER and BIONTECH announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study appeared first on Central Tibetan Administration.